Tempest Therapeutics, Inc. (TPST): Submission of Matters to a Vote of Security Holders
Tempest Therapeutics, Inc. (TPST) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001544227 0001544227 2026-07-27 2026-07-27 0001544227 us-gaap:CommonStockMember 2026-07-27 2026-07-27 0001544227 us-gaap:SeriesAPreferredStockMember 2026-07-27 2026-07-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pu
How this was made
The 30-second read
Why it matters
Because the proposal did not receive sufficient votes at the July 27 meeting, the company adjourned and will reconvene on Aug 17, with no changes to the proposal.
Market read
This creates a discrete corporate event with a known future date, but without new clinical, financial, or deal information.
What to watch
Traders may be over-weighting the first vote failure; the key variable is whether the required 75% threshold is reached at the reconvened meeting, which is not yet disclosed.
Background
Tempest Therapeutics convened a special stockholder meeting to approve a Certificate of Amendment that replaces specified supermajority voting requirements and permits stockholder action by written consent.
Ticker impact
Tempest Therapeutics adjourned its July 27 special meeting because votes were insufficient to approve a charter amendment, reconvening Aug 17.
Likely limited, with volatility concentrated around the Aug 17 reconvened vote outcome rather than a fundamental repricing.
The 8-K discloses meeting quorum/vote status and timing for a specific stockholder proposal, but provides no new operating or financial datapoints.
Market effects
Minimal sector read-across; this is company-specific governance mechanics.
No clear regional spillover indicated.
No global market relevance beyond the issuer’s shareholder vote process.
Counterpoint
The adjournment may simply reflect administrative timing and broader participation goals, not a substantive loss of support.
Key entities
- issuerTempest Therapeutics, Inc.
Nasdaq-listed company filing the 8-K regarding the special meeting vote outcome and reconvening date.
- proxy_solicitation_firmSodali & Co.
Engaged to assist with obtaining adequate votes for the required quorum/approval.
